Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aprepitant with Ondansetron for PONV in High-Risk Patients
NCT01897337Phase 4Completed
- Sponsor
- Yonsei University
- Start
- Jun 2012
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aprepitant in postoperative nausea and vomiting (PONV), sponsored by Yonsei University. Started Jun 2012; status: completed.
02
Drugs
aprepitant
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT01897337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01897337.